With significant weight loss, some users notice changes in facial appearance, often termed as Ozempic face. These changes typically include sagging or loose skin as a result of rapid weight loss
Ongoing research and investigational therapies, such as GIP/GLP-1/glucagon triple agonists, may inform future strategies for sustainable weight loss after discontinuation of weight loss pharmacotherapy
Some are just starting a GLP-1 and want to be proactive
Pharmacopeia (USP)-compliant. Although theyve taken extensive measures to ensure safety, its still important to understand that compounded medications are not FDA-approved, she continued
When to choose the conservative schedule Choose the 6-week schedule if any of these apply to you: Previous strong GI reactions to GLP-1 agonists like semaglutide or tirzepatide History of IBS, GERD, or other chronic digestive conditions BMI under 30 (lower body mass can increase sensitivity to fixed doses) Current use of other medications that affect gastric motility First-time use of any GLP receptor agonist The research is clear on this point
